The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Ganglionic plexi (GP) Ablation in the Surgery for Atrial Fibrillation: Japan GP Ablation trial
Not Applicable
- Conditions
- Patients undergoing cardiac surgery
- Registration Number
- JPRN-jRCT1032180079
- Lead Sponsor
- Ozawa Naomi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients who have indication of atrial fibrillation surgery in the guidelines for non-pharmacotherapy of Cardiac Arrhythmias
Exclusion Criteria
1) Low cardiac function (EF<40%)
2) History of RFCA
3) Use of catechoramine
4) Thrombus in left atrial appendage
5) Pacemaker implantation
6) Non consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of atrial tachycardia and atrial fibrillation in 2 years.
- Secondary Outcome Measures
Name Time Method Recurrence of atrial tachycardia and atrial fibrillation, motality, and major adverse cardiac events in 6 months or 1 year.